Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Dolphins as animal models for type 2 diabetes: sustained, post-prandial hyperglycemia and hyperinsulinemia.

Venn-Watson S, Carlin K, Ridgway S.

Gen Comp Endocrinol. 2011 Jan 1;170(1):193-9. doi: 10.1016/j.ygcen.2010.10.005. Epub 2010 Oct 15.

PMID:
20951701
2.
3.

Ratiometric Measurements of Adiponectin by Mass Spectrometry in Bottlenose Dolphins (Tursiops truncatus) with Iron Overload Reveal an Association with Insulin Resistance and Glucagon.

Neely BA, Carlin KP, Arthur JM, McFee WE, Janech MG.

Front Endocrinol (Lausanne). 2013 Sep 20;4:132. doi: 10.3389/fendo.2013.00132. eCollection 2013.

4.

Evaluation of glucose tolerance, post-prandial hyperglycemia and hyperinsulinemia influencing the incidence of coronary heart disease.

Yamasa T, Ikeda S, Koga S, Kawahara E, Muroya T, Shinboku H, Kohno S.

Intern Med. 2007;46(9):543-6. Epub 2007 May 1.

5.

Post-prandial hyperglycemia. post-prandial hyperglycemia and diabetes.

Gin H, Rigalleau V.

Diabetes Metab. 2000 Sep;26(4):265-72. Review.

6.

Control of post-prandial hyperglycemia--an essential part of good diabetes treatment and prevention of cardiovascular complications.

Hanefeld M, Temelkova-Kurktschiev T.

Nutr Metab Cardiovasc Dis. 2002 Apr;12(2):98-107. Review.

PMID:
12189909
7.

Blood-Based Indicators of Insulin Resistance and Metabolic Syndrome in Bottlenose Dolphins (Tursiops truncatus).

Venn-Watson S, Smith CR, Stevenson S, Parry C, Daniels R, Jensen E, Cendejas V, Balmer B, Janech M, Neely BA, Wells R.

Front Endocrinol (Lausanne). 2013 Oct 9;4:136. doi: 10.3389/fendo.2013.00136. eCollection 2013.

8.

Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.

Carroll MF, Izard A, Riboni K, Burge MR, Schade DS.

Diabetes Care. 2002 Dec;25(12):2147-52.

PMID:
12453952
9.

Hemochromatosis and fatty liver disease: building evidence for insulin resistance in bottlenose dolphins (Tursiops truncatus).

Venn-Watson S, Benham C, Carlin K, DeRienzo D, St Leger J.

J Zoo Wildl Med. 2012 Sep;43(3 Suppl):S35-47.

PMID:
23156704
10.

Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes.

Ai M, Tanaka A, Ogita K, Sekinc M, Numano F, Numano F, Reaven GM.

J Am Coll Cardiol. 2001 Nov 15;38(6):1628-32.

11.

Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus.

Bonora E, Corrao G, Bagnardi V, Ceriello A, Comaschi M, Montanari P, Meigs JB.

Diabetologia. 2006 May;49(5):846-54. Epub 2006 Mar 11.

PMID:
16532323
13.

The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus.

Del Prato S, Tiengo A.

Diabetes Metab Res Rev. 2001 May-Jun;17(3):164-74. Review.

PMID:
11424229
15.

Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.

Henkel E, Menschikowski M, Koehler C, Leonhardt W, Hanefeld M.

Metabolism. 2005 Sep;54(9):1168-73.

PMID:
16125528
16.

Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients.

Mannucci E, Pala L, Monami M, Da Vico L, Bardini G, Dicembrini I, Ciani S, Lamanna C, Marchionni N, Rotella CM.

J Endocrinol Invest. 2010 Mar;33(3):147-50. doi: 10.3275/6497. Epub 2009 Sep 11.

PMID:
19783893
17.

Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.

Raz I, Wilson PW, Strojek K, Kowalska I, Bozikov V, Gitt AK, Jermendy G, Campaigne BN, Kerr L, Milicevic Z, Jacober SJ.

Diabetes Care. 2009 Mar;32(3):381-6. doi: 10.2337/dc08-1671.

18.
19.

[Effect of postprandial hyperglycemia and hyperinsulinemia on vascular responsiveness].

Zamami Y, Takatori S, Iwatani Y, Yamawaki K, Miyashita S, Yabumae N, Takayama F, Mio M, Kawasaki H.

Yakugaku Zasshi. 2008 Mar;128(3):419-24. Review. Japanese.

20.

Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes.

Phillips JW, Barringhaus KG, Sanders JM, Yang Z, Chen M, Hesselbacher S, Czarnik AC, Ley K, Nadler J, Sarembock IJ.

Circulation. 2003 Oct 21;108(16):1994-9. Epub 2003 Sep 29.

Items per page

Supplemental Content

Write to the Help Desk